- Tara Helms | October 06, 2008 5:33 PM | Huntsville, AL
Category:
FDA & Prescription Drugs
The FDA is investigating a report of a possible association between the use of Vytorin and a potentially increased incidence of cancer. Vytorin is a combination of Zocor and Zetia and is generally...
- Michael Roberts | December 15, 2011 6:26 PM | Gadsden, AL
Category:
FDA & Prescription Drugs
An estimated 25.8 million children and adults in the United States—8.3% of the population—have diabetes.
The U.S. Food and Drug Administration (FDA) warned patients that use of...
- Michael Roberts | March 17, 2011 11:57 AM | Gadsden, AL
Category:
Medical Devices & Implants
In the wake of the tragic earthquake and tsunami in Japan, there has been much discussion in the news about the risk of a nuclear disaster and the health effects of radiation exposure for the...
- Wendi Lewis | May 14, 2008 5:39 PM | Montgomery, AL
Category:
Miscellaneous
A class action notice known as Skelton v. Central United Life Insurance Company was mailed to policyholders who possessed a cancer policy during the time frame of February 2003 through April 2008. Policyholders must opt out of this class action by June 3, 2008, if they wish to pursue an individual claim.
- Jason Knowles | July 16, 2009 2:38 PM | Gadsden, AL
Category:
Workplace Injuries
The U. S. Supreme Court has recently ruled that a Tennessee railroad worker is not entitled to the $5 million awarded him by a jury for his long-term exposure to asbestos. In CSX Transp., Inc. v....
- Tom Methvin | September 03, 2008 5:35 PM | Montgomery, AL
Category:
FDA & Prescription Drugs
Vytorin, manufactured by Merck & Co. and Schering-Plough was introduced as the newest weapon in the fight against “bad” cholesterol. But last week the U.S. Food and Drug Administration dealt...